The latest price target for Bionomics (NASDAQ:BNOX) was reported by HC Wainwright & Co. on August 1, 2024. The analyst firm set a price target for $8.00 expecting BNOX to rise to within 12 months (a possible 3212.63% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Bionomics (NASDAQ:BNOX) was provided by HC Wainwright & Co., and Bionomics reiterated their buy rating.

The last upgrade for Bionomics Ltd happened on September 28, 2023 when HC Wainwright & Co. raised their price target to $8. HC Wainwright & Co. previously had a neutral for Bionomics Ltd.

The last downgrade for Bionomics Ltd happened on December 20, 2022 when Evercore ISI Group changed their price target from $17 to $6 for Bionomics Ltd.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionomics was filed on August 1, 2024 so you should expect the next rating to be made available sometime around August 1, 2025.

While ratings are subjective and will change, the latest Bionomics (BNOX) rating was a reiterated with a price target of $8.00 to $8.00. The current price Bionomics (BNOX) is trading at is $0.24, which is out of the analyst’s predicted range.